Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gadobutrol vs SOC Contrast for Brain Lesion DCE-MRI
NCT02967380Terminated
- Sponsor
- University of Southern California
- Start
- Dec 2011
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of gadobutrol in multiple sclerosis (MS), glioma and brain metastases, sponsored by University of Southern California. Primary endpoints: Agreement of using Magnevist® or Multihance versus Gadavist® on glioma grading up to 7 days, Agreement in identifying the number of cerebral metastases up to 7 days and 3 more. Started Dec 2011; status: terminated.
02
Drugs
gadobutrol
03
Conditions
multiple sclerosis (MS)gliomabrain metastases
Beyond the preview
Go deeper on NCT02967380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02967380.